Antimycin A inhibits alpha-herpesvirus replication by disrupting the formation of pyrimidinosomes
Antimycin A emerges as a promising lead candidate for the development of antiviral therapies against alpha-herpesvirus infections.
Authors
- Yingjie Sun (ORCID: https://orcid.org/0000-0002-6086-5722)
- Ning Tang (ORCID: https://orcid.org/0000-0003-4702-9399)
- Lijing Wo
- Menghang Wang (ORCID: https://orcid.org/0000-0002-0776-5917)
- Yan‐Dong Tang (ORCID: https://orcid.org/0000-0002-5690-2690)
- Rui Huang (ORCID: https://orcid.org/0000-0002-0635-9239)
- Xin Yin (ORCID: https://orcid.org/0000-0003-2357-6718)
- Ye Guo (ORCID: https://orcid.org/0009-0009-3512-9000)
- Liang Dong (ORCID: https://orcid.org/0000-0002-8588-0398)
- Yubo Zhao
Institutions
- Shanghai Veterinary Research Institute (CN)
- Chinese Academy of Agricultural Sciences (CN)
- Harbin Veterinary Research Institute (CN)
Publication Details
- Journal
- Journal of Advanced Research
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1016/j.jare.2025.05.016
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Heilongjiang Province
- Science Fund for Distinguished Young Scholars of Heilongjiang Province